Non-coding genetic elements of lung cancer identified using whole genome sequencing in 13,722 Chinese
A substantial portion of lung cancer-associated genetic elements in East Asian populations remains unidentified, underscoring the need for large-scale genome-wide studies, particularly on non-coding regulation. We conducted a whole genome sequencing (WGS)-based genome-wide scan in 13,722 Chinese individuals to identify regulatory elements associated with lung cancer. We verified common-variant-based loci by meta-analysis across the available East Asian studies. Integrating a genome-transcriptome reference panel of lung tissue in 297 Chinese, we bridged the variant-lung cancer associations, highlighting genes including TP63 and DCBLD1. Implementing the STAAR pipeline for rare variant aggregate analysis, we identified and replicated novel genes, including PARPBP, PLA2G4C, and RITA1 in the context of non-coding regulation. Adapting a deep learning-based approach, potential upstream regulators such as TP53, MYC, ZEB1, and NFKB1 were revealed for the lung cancer-associated genes. These findings offered crucial insights into the non-coding regulation for the etiology of lung cancer, providing additional potential targets for intervention.
Authors
- Kejia Hu (ORCID: https://orcid.org/0000-0002-1175-3580)
- Fang Hu
- Kui Wu (ORCID: https://orcid.org/0000-0002-6857-7231)
- Xifeng Wu (ORCID: https://orcid.org/0000-0003-2980-8129)
- Xiaohang Xu (ORCID: https://orcid.org/0000-0002-3391-4701)
- Fangming Yang
- Ming Wu (ORCID: https://orcid.org/0000-0002-1009-5387)
- Huakang Tu (ORCID: https://orcid.org/0000-0002-8494-7327)
- Xin Jin (ORCID: https://orcid.org/0000-0001-7554-4975)
- Wenyuan Li (ORCID: https://orcid.org/0000-0001-6196-9964)
- Dan Zhou (ORCID: https://orcid.org/0000-0002-5313-8164)
- Fuqiang Li (ORCID: https://orcid.org/0000-0002-2085-1457)
- Tian Luo
- Liyang Sun
- Qilong Tan
- Hanyi Zhou
- Yuanxing Tu (ORCID: https://orcid.org/0009-0001-5259-4643)
- Min Yang (ORCID: https://orcid.org/0000-0001-9487-6828)
- Yun Zhu (ORCID: https://orcid.org/0000-0001-6656-3891)
- Weifang Zheng
Institutions
- BGI Group (China) (CN)
- Zhejiang Cancer Hospital (CN)
- Zhejiang Lab (CN)
- Hangzhou Xixi hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Hangzhou Cancer Hospital (CN)
- BGI Genomics
- South China University of Technology (CN)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-08-09
- DOI
- https://doi.org/10.1038/s41467-025-62459-6
- Citations
- 4
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 3.22